Inside Innovation

Seattle-based biotech company Proniras raised $4.65 million in a recent Series B funding round to support its tezampanel, an opiate withdrawal therapy and Proniras’ leading

Kayla Young, chief operating officer at Seattle-based life science company Phase Genomics, discusses her experience in Washington’s life sciences and offers insights to other employees

Seattle-based life science company Lundbeck Therapeutics is prioritizing its long-term growth efforts, with recently hired CEO Charl van Zyl looking to facilitate strategic and systematic

Seattle is the fourth most walkable city in America, according to a new report from Smart Growth America. The rankings were drawn from two databases

Life science companies Prevencio, Adaptive Biotechnologies (Adaptive) and Bristol-Myers Squibb are spearheading some of Washington state’s major innovations in life science and biotechnology. Kirkland-based Prevencio

Seattle-based biotech startup Parse Biosciences acquired Biomage, a software development company that analyzes data of single-cell RNA. The deal will support Parse Biosciences’ research of

Three executives discussed the inclusivity and supportiveness of Seattle’s economy as it pertains to women in business. Seattle, which holds significant female involvement across government

Seattle-based Swedish Health Services (Swedish) completed its 500th MitraClip procedure nearly one year ago, and the 10-year program is now one of the top five

The University of Washington plans to begin construction this year on its Brightwork building as part of its Portage Bay Crossing redevelopment program. The building,

Seattle-based biotech company AGC Biologics announced that it will be adding a new preclinical and commercial manufacturing facility to its Yokohama Technical Center in Japan.

Seattle-based companies Bonum Therapeutics and Cajal Neuroscience are among BioSpace’s life science startups to watch in 2024. BioSpace’s NextGen Class of 2024 identified this year’s